Caribou Biosciences Inc (NASDAQ:CRBU) price on Tuesday, December 24, fall -5.59% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.69.
A look at the stock’s price movement, the close in the last trading session was $1.79, moving within a range at $1.65 and $1.805. The beta value (5-Year monthly) was 2.263. Turning to its 52-week performance, $8.33 and $1.50 were the 52-week high and 52-week low respectively. Overall, CRBU moved -15.33% over the past month.
Caribou Biosciences Inc’s market cap currently stands at around $144.48 million, with investors looking forward to this quarter’s earnings report slated for in January.
The average forecast suggests down to a -48.20% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 9.13M, representing a -73.51% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CRBU is a 100% Sell. On the other hand, the stock is on average a Hold as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend CRBU as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
CRBU’s current price about -15.21% and -18.52% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 35.09, while 7-day volatility ratio is 7.68% and 8.37% in the 30-day chart. Further, Caribou Biosciences Inc (CRBU) has a beta value of 2.30, and an average true range (ATR) of 0.16. Analysts have given the company’s stock an average 52-week price target of $3, forecast between a low of $3 and high of $3. Looking at the price targets, the low is -77.51% off current price level while to achieve the yearly target high, price needs to move -77.51%. Nonetheless, investors will most likely welcome a -77.51% jump to $3 which is the analysts’ median price.
If we refocus on Caribou Biosciences Inc (NASDAQ:CRBU), historical trading data shows that trading volumes averaged 1.33 over the past 10 days and 1.34 million over the past 3 months. The company’s latest data on shares outstanding shows there are 90.55 million shares.
The 12.56% of Caribou Biosciences Inc’s shares are in the hands of company insiders while institutional holders own 58.66% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 8.62 million on 2024-11-29, giving us a short ratio of 4.55. The data shows that as of 2024-11-29 short interest in Caribou Biosciences Inc (CRBU) stood at 997.00004 of shares outstanding, with shares short falling to 9.94 million registered in 2024-10-31. Current price change has pushed the stock -70.15% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CRBU stock continues to rise going into the next quarter.
